Locations:
Search
Cleveland Clinic's Nursing Institute hosted an ideation session where 20+ nursing and pharmacy caregivers collaborated to address medication administration safety challenges, generating over 224 unique ideas aimed at enhancing patient safety and reducing workflow inefficiencies in the inpatient setting.
Cleveland Clinic inventors have pioneered AI-driven software that analyzes retinal imaging data with unprecedented precision. Led by Justis P. Ehlers, MD, and Sunil Srivastava, MD, this technology extracts critical information from optical coherence tomography scans to enhance disease detection, predict treatment outcomes, and establish new endpoints for clinical trials in ophthalmology.
Cleveland Clinic's Innovation Fellows program has sparked the development of PowerCut, a tool modernizing spinal rod manipulation techniques unchanged for decades. Advanced through the collaborative work of Kyle O'Laughlin, MS, Lead Research Technologist, Biomedical Engineering, Cleveland Clinic, this device aims to transform scoliosis surgeries by replacing manual bending methods with a smaller, more efficient alternative that streamlines procedures and expands capabilities across surgical teams.
Cleveland Clinic Innovations is proud to highlight the creativity and problem-solving spirit of our nurses through the Nurse Inventor Spotlight series. This series highlights nurses’ innovation journeys, inspirations, how nurses and teams identify unmet needs, and the impact of unmet needs and innovations on patients and caregivers.
by Saqib Sachani, PhD, MBA, Director, Innovations Business Development and Licensing
By Mohamed Ramadan, PhD, MBA, General Manager, Cleveland Clinic Innovations Development
Cleveland Clinic developed Autism Eyes, an eye-tracking technology that detects autism markers by analyzing how children view images. Acquired in early 2024, this technology aims to reduce the typical one-to-three-year delay between noticing symptoms and receiving a formal autism diagnosis.
Cleveland Clinic Innovations (CCI) demonstrated exceptional performance in 2024, securing 144 patents, generating $27 million in licensing revenue, and investing $29 million in companies. The organization's achievements spanned technology development, international expansion, and capital raises, solidifying its position as a transformative force in healthcare innovation.
LifeArc and Cleveland Clinic sign 10-year Master Services Agreement to develop novel monoclonal antibody-based therapeutics, building on their successful collaboration since 2019. The agreement combines LifeArc's three decades of expertise in antibody humanization with Cleveland Clinic's renowned capabilities, aiming to address unmet medical needs in areas including cancer and complement-mediated diseases.
